Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 95

1.

Differences in regulation and function of E-cyclins in human cancer cells.

Geng Y, Sicinski P.

Cell Cycle. 2013 Apr 15;12(8):1165. doi: 10.4161/cc.24487. Epub 2013 Apr 2. No abstract available.

PMID:
23549169
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Cyclin E2 induces genomic instability by mechanisms distinct from cyclin E1.

Caldon CE, Sergio CM, Burgess A, Deans AJ, Sutherland RL, Musgrove EA.

Cell Cycle. 2013 Feb 15;12(4):606-17. doi: 10.4161/cc.23512. Epub 2013 Jan 16.

PMID:
23324395
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Differences in degradation lead to asynchronous expression of cyclin E1 and cyclin E2 in cancer cells.

Caldon CE, Sergio CM, Sutherland RL, Musgrove EA.

Cell Cycle. 2013 Feb 15;12(4):596-605. doi: 10.4161/cc.23409. Epub 2013 Jan 16.

PMID:
23324394
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Similar, not the same: diverse roles and regulation of cyclin Es.

Spoerri L, Gabrielli B.

Cell Cycle. 2013 Mar 1;12(5):715. doi: 10.4161/cc.23909. Epub 2013 Feb 19. No abstract available.

PMID:
23422855
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Estrogen regulation of cyclin E2 requires cyclin D1 but not c-Myc.

Caldon CE, Sergio CM, Schütte J, Boersma MN, Sutherland RL, Carroll JS, Musgrove EA.

Mol Cell Biol. 2009 Sep;29(17):4623-39. doi: 10.1128/MCB.00269-09. Epub 2009 Jun 29.

PMID:
19564413
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Cyclin E2 overexpression is associated with endocrine resistance but not insensitivity to CDK2 inhibition in human breast cancer cells.

Caldon CE, Sergio CM, Kang J, Muthukaruppan A, Boersma MN, Stone A, Barraclough J, Lee CS, Black MA, Miller LD, Gee JM, Nicholson RI, Sutherland RL, Print CG, Musgrove EA.

Mol Cancer Ther. 2012 Jul;11(7):1488-99. doi: 10.1158/1535-7163.MCT-11-0963. Epub 2012 May 7.

PMID:
22564725
[PubMed - indexed for MEDLINE]
Free Article
7.

Expression of cyclins E1 and E2 during mouse development and in neoplasia.

Geng Y, Yu Q, Whoriskey W, Dick F, Tsai KY, Ford HL, Biswas DK, Pardee AB, Amati B, Jacks T, Richardson A, Dyson N, Sicinski P.

Proc Natl Acad Sci U S A. 2001 Nov 6;98(23):13138-43. Epub 2001 Oct 30.

PMID:
11687642
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Integrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancer.

Agarwal R, Gonzalez-Angulo AM, Myhre S, Carey M, Lee JS, Overgaard J, Alsner J, Stemke-Hale K, Lluch A, Neve RM, Kuo WL, Sorlie T, Sahin A, Valero V, Keyomarsi K, Gray JW, Borresen-Dale AL, Mills GB, Hennessy BT.

Clin Cancer Res. 2009 Jun 1;15(11):3654-62. doi: 10.1158/1078-0432.CCR-08-3293. Epub 2009 May 26.

PMID:
19470724
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

SCF(Fbxw7/hCdc4) targets cyclin E2 for ubiquitin-dependent proteolysis.

Klotz K, Cepeda D, Tan Y, Sun D, Sangfelt O, Spruck C.

Exp Cell Res. 2009 Jul 1;315(11):1832-9. doi: 10.1016/j.yexcr.2008.11.017. Epub 2008 Dec 3.

PMID:
19084516
[PubMed - indexed for MEDLINE]
10.

Effects of E2F1-cyclin E1-E2 circuit down regulation in hepatocellular carcinoma cells.

Farra R, Dapas B, Pozzato G, Scaggiante B, Agostini F, Zennaro C, Grassi M, Rosso N, Giansante C, Fiotti N, Grassi G.

Dig Liver Dis. 2011 Dec;43(12):1006-14. doi: 10.1016/j.dld.2011.07.007. Epub 2011 Aug 9.

PMID:
21831731
[PubMed - indexed for MEDLINE]
11.

Selective usage of D-Type cyclins by Ewing's tumors and rhabdomyosarcomas.

Zhang J, Hu S, Schofield DE, Sorensen PH, Triche TJ.

Cancer Res. 2004 Sep 1;64(17):6026-34.

PMID:
15342383
[PubMed - indexed for MEDLINE]
Free Article
12.

Which cyclin E prevails as prognostic marker for breast cancer? Results from a retrospective study involving 635 lymph node-negative breast cancer patients.

Sieuwerts AM, Look MP, Meijer-van Gelder ME, Timmermans M, Trapman AM, Garcia RR, Arnold M, Goedheer AJ, de Weerd V, Portengen H, Klijn JG, Foekens JA.

Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3319-28.

PMID:
16740753
[PubMed - indexed for MEDLINE]
Free Article
13.

Loss of cyclin E requirement in cell growth of an oral squamous cell carcinoma cell line implies deregulation of its downstream pathway.

Yamada S, Sumrejkanchanakij P, Amagasa T, Ikeda MA.

Int J Cancer. 2004 Aug 10;111(1):17-22.

PMID:
15185338
[PubMed - indexed for MEDLINE]
14.

Role of E2F1-cyclin E1-cyclin E2 circuit in human coronary smooth muscle cell proliferation and therapeutic potential of its downregulation by siRNAs.

Dapas B, Farra R, Grassi M, Giansante C, Fiotti N, Uxa L, Rainaldi G, Mercatanti A, Colombatti A, Spessotto P, Lacovich V, Guarnieri G, Grassi G.

Mol Med. 2009 Sep-Oct;15(9-10):297-306. doi: 10.2119/molmed.2009.00030. Epub 2009 Jun 25.

PMID:
19603101
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Deregulation of cyclin E2 expression and associated kinase activity in primary breast tumors.

Payton M, Scully S, Chung G, Coats S.

Oncogene. 2002 Dec 5;21(55):8529-34.

PMID:
12466974
[PubMed - indexed for MEDLINE]
Free Article
16.

The prognostic value and overexpression of cyclin A is correlated with gene amplification of both cyclin A and cyclin E in breast cancer patient.

Husdal A, Bukholm G, Bukholm IR.

Cell Oncol. 2006;28(3):107-16.

PMID:
16823179
[PubMed - indexed for MEDLINE]
17.

Cyclin D and oncogenesis.

Motokura T, Arnold A.

Curr Opin Genet Dev. 1993 Feb;3(1):5-10. Review.

PMID:
8453274
[PubMed - indexed for MEDLINE]
18.

HuR contributes to cyclin E1 deregulation in MCF-7 breast cancer cells.

Guo X, Hartley RS.

Cancer Res. 2006 Aug 15;66(16):7948-56.

PMID:
16912169
[PubMed - indexed for MEDLINE]
Free Article
19.

Deregulated expression of cyclin D1 and other cell cycle-related genes in carcinogen-induced rat mammary tumors.

Sgambato A, Han EK, Zhang YJ, Moon RC, Santella RM, Weinstein IB.

Carcinogenesis. 1995 Sep;16(9):2193-8.

PMID:
7554074
[PubMed - indexed for MEDLINE]
20.

Low molecular weight cyclin E overexpression shortens mitosis, leading to chromosome missegregation and centrosome amplification.

Bagheri-Yarmand R, Biernacka A, Hunt KK, Keyomarsi K.

Cancer Res. 2010 Jun 15;70(12):5074-84. doi: 10.1158/0008-5472.CAN-09-4094. Epub 2010 Jun 8.

PMID:
20530685
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk